Australia's largest stock trading and investment forum Australia's #1 stock forum

ATX

Click for more information

0.00%

6.1¢ amplia therapeutics limited

Despite having 11 sites up and running, the timeline for 26...

First 43 Last

Share
Profile

Follow
Duke2

753 Posts.

192

19/03/24

22:49

Post #: 72969263
Share

Originally posted by vrs37: ↑

Thanks. So it’s important to know when the 26th gets included and expected follow up from the time of 26th starting in trial to estimate conservative time frame. Median duration of gem/nab paclitaxel in the original Mpact trial was 4 months. So if we use that assumption, and ATX saying mid- year for results, let’s say June 30, working back 4 months means 26th should have been enrolled end Feb.
However if they get lucky and all 6 + objective responses they need to pass futility occur in first handful of patients, that’s great!

Expand

Despite having 11 sites up and running, the timeline for 26 patients enrolled and interim analysis for mid 2024 seems a stretch for me. Would love to be proven otherwise of course

Last edited by Duke2: 19/03/24

ATX Price at posting: 7.7¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

There are more pages in this discussion • 16 more messages in this thread...

First 43 Last

Add ATX (ASX) to my watchlist

(20min delay)
Last 6.1¢		Change 0.000(0.00%)		Mkt cap ! $11.83M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	7398	6.1¢

Sellers (Offers)

Price($)	Vol.	No.
6.3¢	97556	1

View Market Depth

No.	Vol.	Price($)
2	7398	0.061
4	444559	0.060
2	109000	0.058
2	190363	0.055
1	18509	0.054

Price($)	Vol.	No.
0.063	97556	1
0.064	127921	1
0.065	297798	1
0.070	20000	1
0.080	16129	1

Last trade - 10.10am 30/04/2024 (20 minute delay)

ATX (ASX) Chart

Day chart unavailable